dihexa tablet EllieMD

The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York

BPC-157 Micro-Dosing: Is Less More for Chronic Conditions?

Tree of Life Medical

The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York

Big FDA review coming this July. Here's what athletes and patients should know about BPC-157, TB-500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #